Revealing insights on the oncology patent landscape to drive litigation strategy

The findings in this report were developed using the Darts-ip™ database of IP litigation from Clarivate, the largest, global IP case-law database with information on more than 8.6 million cases worldwide. We combined Darts-ip™ patent litigation data from 141 countries with the International Non-proprietary Name (INN) dataset from Cortellis Generics Intelligence™.

We retrieved the studied sample of 1,082 patent families based on the Cortellis Generics Intelligence dataset of 942 INNs related to antineoplastic and immunomodulating agents. This generated a universe of 1,683 infringement cases and validity challenges – including invalidity actions, opposition actions and Inter Partes Review proceedings (IPR) – with a filing date from 2011 through 2021. We also established a control group dataset containing all cases within the pharmaceutical field.

If you would like to learn more about how Clarivate integrates litigation data from Darts-ip with data from Cortellis Generics Intelligence or how to order a custom report exploring these datasets please fill out the form below.